Trial Profile
Real world safety study of collagenase clostridium histolyticum (Xiaflex) injection in men with Peyronie's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jun 2016
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Peyronie's disease
- Focus Adverse reactions; Therapeutic Use
- 13 Jun 2016 New trial record
- 10 May 2016 Results (safety analysis,n=55) presented at the 111th Annual Meeting of the American Urological Association